Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2010, PBM Capital Group is a healthcare-focused investment firm based in Charlottesville, Virginia, with an additional office in New York City. The firm specializes in the pharmaceutical and life sciences industries and was established by Paul Manning, who previously founded PBM Products, a leading provider of private label infant formula. PBM Capital manages investments aimed at improving and saving lives.
PBM Capital invests in companies developing pharmaceutical and biological products, providing capital and strategic resources to address unmet medical needs. The firm seeks to partner with entrepreneurs whose goals align with its investment thesis, leveraging its operational expertise and industry knowledge to enhance the development of innovative healthcare solutions.
Notable portfolio companies include AveXis, acquired by Novartis for its gene therapy innovations; Dova Pharmaceuticals, which completed an initial public offering; and Verrica Pharmaceuticals, another biopharmaceutical company that has gone public.
Email your pitch deck to info@pbmcap.com for consideration.
Yes, PBM Capital often leads investment rounds, particularly in early to growth-stage companies within its focus sectors.
The firm is open to follow-on investments, especially if the company continues to align with its investment thesis and demonstrates growth potential.
Specific fund size details are not publicly available, but the firm has a history of backing significant biotech and healthcare ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.